These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 6383127

  • 1. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W.
    Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
    [Abstract] [Full Text] [Related]

  • 2. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
    Van den Brande P, Maurel A.
    Angiology; 1998 Feb; 49(2):105-14. PubMed ID: 9482510
    [Abstract] [Full Text] [Related]

  • 3. Buflomedil for intermittent claudication.
    De Backer TL, Vander Stichele RH, Bogaert MG.
    Cochrane Database Syst Rev; 2001 Feb; (1):CD000988. PubMed ID: 11279700
    [Abstract] [Full Text] [Related]

  • 4. A review of long-term safety data with buflomedil.
    Bachand RT, Dubourg AY.
    J Int Med Res; 1990 Feb; 18(3):245-52. PubMed ID: 2193838
    [Abstract] [Full Text] [Related]

  • 5. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G, Balzer K, Bisler H, Klüken N, Mahfoud Y, Müller-Wiefel H, Unkel B, Ziegler W.
    Dtsch Med Wochenschr; 1982 Dec 24; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract] [Full Text] [Related]

  • 6. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
    Andreozzi GM, Lepore R.
    Clin Ter; 1990 Nov 30; 135(4):273-81. PubMed ID: 2150026
    [Abstract] [Full Text] [Related]

  • 7. Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
    Trübestein G, Böhme H, Heidrich H, Heinrich F, Hirche H, Maass U, Mörl H, Rudofsky G.
    Angiology; 1984 Nov 30; 35(11):701-8. PubMed ID: 6388425
    [Abstract] [Full Text] [Related]

  • 8. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
    Mozzi E, Chiurazzi D, Spinola A, Annoni F, Germiniani R.
    J Int Med Res; 1985 Nov 30; 13(6):317-21. PubMed ID: 4076530
    [Abstract] [Full Text] [Related]

  • 9. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L, Gandolfo AM, Utz C.
    MMW Munch Med Wochenschr; 1984 Mar 02; 126(9):247-8. PubMed ID: 6425678
    [No Abstract] [Full Text] [Related]

  • 10. Buflomedil for intermittent claudication.
    de Backer TL, Bogaert M, Vander Stichele R.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD000988. PubMed ID: 17943749
    [Abstract] [Full Text] [Related]

  • 11. A meta-analysis of randomized, double-blind, placebo-controlled studies of the effect of buflomedil on intermittent claudication.
    Walker GA, Mac Hannaford JC.
    Fundam Clin Pharmacol; 1995 Oct 17; 9(4):387-94. PubMed ID: 8566940
    [Abstract] [Full Text] [Related]

  • 12. Buflomedil for intermittent claudication.
    de Backer TL, Bogaert M, Vander Stichele R.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD000988. PubMed ID: 18253982
    [Abstract] [Full Text] [Related]

  • 13. Buflomedil for intermittent claudication.
    de Backer TL, Vander Stichele R.
    Cochrane Database Syst Rev; 2013 Mar 28; 2013(3):CD000988. PubMed ID: 23543509
    [Abstract] [Full Text] [Related]

  • 14. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients.
    Forconi S, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Ralli L, Guerrini M, Di Perri T.
    J Int Med Res; 1984 Mar 28; 12(3):188-92. PubMed ID: 6734922
    [No Abstract] [Full Text] [Related]

  • 15. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
    Diehm C, Eckstein M, Hübsch-Müller C.
    Vasa; 1989 Mar 28; 18(1):40-7. PubMed ID: 2648691
    [Abstract] [Full Text] [Related]

  • 16. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 17. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec 12; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 18. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F, Meites G, Rousseau H, Staffin C, Allaert FA, Pelat P.
    Ann Radiol (Paris); 1994 Dec 12; 37(3):239-44. PubMed ID: 8092756
    [Abstract] [Full Text] [Related]

  • 19. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V, Mikhailidis DP, Barradas MA, Jeremy JY, Gracey L, Dandona P.
    Int J Clin Pharmacol Res; 1988 Dec 12; 8(5):377-81. PubMed ID: 3229875
    [Abstract] [Full Text] [Related]

  • 20. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
    Peters H, Kieser M, Hölscher U.
    Vasa; 1998 May 12; 27(2):106-10. PubMed ID: 9612115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.